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Introduction
Despite improvements in the medical and surgical care
of burn patients, no significant improvement has been doc-
umented on the mortality of burn patients in developing coun-
tries. Infection is a major complication of burn injury. Dis-
ruption of the normal skin barrier and compromised immune
responses increase the vulnerability of burn patients to seri-
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SUMMARY. Burn wound infection is a major cause of morbidity and mortality in burn victims. Pseudomonas and Acinetobacter
species are among the most common organisms complicating burn wounds. Presence of extended spectrum β-lactamase (ESBL)
and metallo-β-lactamase (MBL) genes plays an important role in spreading β-lactam resistant strains of these organisms and is a
serious condition in the treatment of the affected patients. As a result, we aimed to determine the prevalence of SHV, TEM, PER
and VIM β-lactamases in Pseudomonas and Acinetobacter species isolates from burn wound swabs of children with burn injury.
In this descriptive observational study, 107 Pseudomonas and Acinetobacter isolates collected from burn patients were subjected
to PCR assay. Using PCR method and DNA sequencing, the existence of SHV-, TEM-, PER- and VIM-type β-lactamase encod-
ing genes were determined. Out of the 107 Pseudomonas and Acinetobacter isolates, 66 (77.6%) were ESBL positive, 26.2% were
positive for SHV gene, 37.4% were positive for TEM gene, 14% were positive for PER gene and 15.9% of them harbored VIM
gene. More than half of the Pseudomonas and Acinetobacter strains in our pediatric burn unit harbor β-lactamase encoding genes
that make them resistant to a wide range of β-lactam antibiotics. Consequently, it is suggested to choose an appropriate antibiotic
regimen based on the antibiogram pattern of the strains.
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RÉSUMÉ. Les infections cutanées sont une cause majeure de morbidité et de mortalité chez les brûlés. Pseudomonas et Acineto-
bacter sont parmi les micro-organismes les plus communs chez les brûlés. La présence des gènes codant les β-lactamases à spectre
étendu (BLSE) et métallo-β-lactamases (MBL) joue un rôle important dans la dissémination des souches résistantes et obère le
traitement des patients infectés. Nous avons étudié la prévalence des gènes encodant pour des enzymes des groupes SHV, TEM,
PER et VIM dans des isolats de Pseudomonas et Acinetobacter chez les brûlés pédiatriques, grâce à des techniques de PCR. Dans
cette étude observationnelle descriptive, 107 isolats de Pseudomonas et Acinetobacter, obtenus chez des patients brûlés ont été étu-
diés. Plus des 3/4 des souches de Pseudomonas et Acinetobacter expriment une BLSE (26.2% SHV; 37.4% TEM; 14% PER; 15.9%
VIM), ce qui les rend résistants à de nombreuses β-lactamines. Il est donc suggéré de choisir un traitement antibiotique appro-
prié, basé sur l’antibiogramme des souches infectantes.
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ous infections. Furthermore, burn wounds contain a large
amount of necrotic tissue and protein-rich exudates which
provide a rich growth medium for colonized organisms.1, 2
Burn wound infection is responsible for 50 to 75% of in-
hospital deaths. Moreover, infection of burn wounds leads
to graft failure, increased tissue necrosis, and scarring.3-5
Serious infections caused by Pseudomonas aeruginosa
and Acinetobacter spp. are common complications in burn
pediatric patients leading to substantial morbidity and mor-
tality. Pseudomonas aeruginosa and Acinetobacter bau-
mannii are two important nosocomial pathogens that are
highly amenable to multidrug resistance. Moreover, Gram-
negative bacteria including Pseudomonas and Acinetobacter
species (spp.) are usually the predominant etiologies of blood-
stream and wound infections in the pediatric population.6, 7
Pseudomonas aeruginosa is an opportunistic Gram-
negative organism. Several mechanisms including beta-lac-
tamase production, up regulation of efflux systems, and
decreased outer membrane permeability result in beta-lac-
tam resistance in P. aeruginosa and render the organism
very difficult to treat or eradicate, consequently predis-
posing the burn wound and medical equipment and de-
vices in burn units to Pseudomonas contamination and in-
fection.8, 9
Recently, Acinetobacter spp. has emerged as a main
cause of nosocomial infections associated with consider-
able morbidity and mortality.10, 11 Acinetobacter spp. exhibit
multidrug resistance through production of β-lactamases,
alterations in outer membrane proteins (OMPs) and peni-
cillin-binding proteins (PBPs), and increased activity of ef-
flux pumps.11, 12-15 It is believed that Acinetobacter spp. are
resistant to almost all currently available antimicrobial
agents, including the aminoglycosides, the quinolones, and
broad-spectrum β-lactams.16 The broad spectrum of antibi-
otic resistance in these organisms in association with their
unique survival capabilities represents a major challenge
in the treatment of these types of infections in hospitals,
especially burn units. Most strains of Acinetobacter are re-
sistant to cephalosporins and resistance to carbapenems is
increasingly common.17, 18
Spread of beta-lactamase producing mediated antibi-
otic resistance in P. aeruginosa and Acinetobacter spp. is
a major concern in pediatric burn units. As a result, in the
present investigation, we aimed to assess the presence of
beta lactamase producing genes in Pseudomonas and Acine-
tobacter strains isolated from the burn wounds of pediatric
burn patients. 
Patients and methods
This cross-sectional study was conducted at the Pedi-
atric ward of Motahari Burn center in Tehran, Iran from
September 2012 to June 2013. Hospitalized patients aged
1 to 18 years old with burn injury were enrolled if their
burn wound culture was positive either for Pseudomonas
or Acinetobacter strains.
The study was reviewed and approved by the Institu-
tional Review Board at Iran University of Medical Sci-
ences and a written informed consent was obtained from
parents or guardians of all participants.
On admission, patients with burns greater than 20% of
the Total Body Surface Area (TBSA) were resuscitated with
intravenous fluid (20 mL/kg per hour) and a Foley catheter
was placed and urine output was monitored hourly, the goal
being 1.0 mL/kg per hour. Once the extent of the burn was
estimated according to Lund–Browder chart, resuscitation
continued using the Parkland formula (approximately 6
mL/kg per percent TBSA of burn). The burn depth was es-
timated clinically by an experienced trauma surgeon. A top-
ical anti-microbial agent (preferentially silver sulphadiazine)
was applied to burn wounds and cotton gauze dressings
used for all patients were changed daily. Sampling from
burn wounds was carried out using swabs from various
parts of the wound before cleansing and application of the
topical antimicrobial. Swabs were transferred into sterile
tubes immediately following sampling and sent to a mi-
crobiology laboratory. Identification of isolates was per-
formed according to the conventional bacteriologic meth-
ods or using commercial identification kits. In cases with
Pseudomonas spp. or Acinetobacter spp. positive cultures,
samples were subjected to PCR analysis to examine the β-
lactamase producing genes including PER, SHV, TEM (ex-
tended-spectrum β-lactamase encoding genes) and VIM (a
metallo-β-lactamase encoding gene, also known as car-
bapenemase). Patients received antibiotic therapy only if
there was a clinical suspicion of infection (i.e. change in
appearance or color of wound or positive blood or wound
cultures) at the discretion of the treating surgeon.
Statistical analysis
All analyses were conducted by Statistical Package for
Social Sciences (SPSS) software, version 19 (SPSS Inc.,
Chicago, IL, USA). Continuous data are presented as
mean± SD. Unpaired t-test was used for comparison of
age of patients between Pseudomonas and Acinetobacter
positive cultures. Categorical data were given as frequen-
cies and percentages. A P value of <0.05 was considered
statistically significant.
Results
There were 107 patients including 84 boys (78.5%)
and 23 (21.5%) girls. The mean age was 3.8± 2.5 years.
The burn size in 43 patients (40.2%) was less than 30%
TBSA, in 29 patients (27.1%) between 31-40% of TBSA,
in 17 (15.9%) patients it was between 41-50% and in 18
patients (16.8%) the burn size was more than 50% TBSA. 
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In 55 patients (51.5%), depth and severity of burn were
at stage IIb, in 27 (25.2%) patients at stages III to IV, in
12 (11.2%) at a combination of II and III, and in the re-
maining 13 (12.1) patients at a combination of stage III
and IV. The isolated strains included Pseudomonas spp.
in 76 (71%) patients and Acinetobacter spp. in 31 (29%)
patients. No significant difference was seen between the
isolated strains from burn wounds with respect to the pa-
tients` age (p=0.622, Fig. 1). 
Table I shows the frequency of each of the beta-lac-
tamase producing genes (PER, SHV, TEM and VIM) in
the isolated strains of Pseudomonas and Acinetobacter. 
The distribution of β-lactamase producing genes in the
isolated strains of Pseudomonas and Acinetobacter based
on gender is shown in Fig. 2. Figs. 3 and 4 also demon-
strate the distribution of β-lactamase producing genes in
the isolated strains of Pseudomonas and Acinetobacter
based on the size and degree of the burn, respectively. 
Fig. 1 - No significant difference was seen in the result of burn
wound swab cultures and age of the participants (p=0.62).
Fig. 2 - The distribution of β-lactamase producing genes in the iso-
lated strains of Pseudomonas and Acinetobacter is shown based on
the gender of participants.
Fig. 3 - The distribution of β-lactamase producing genes in the iso-
lated strains of Pseudomonas and Acinetobacter is shown based on
the extent of burn as % of Total Body Surface Area (TBSA).
Fig. 4 - The distribution of β-lactamase producing genes in the iso-
lated strains of Pseudomonas and Acinetobacter is shown based on
the degree of burn.
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Discussion
Burn wounds represent the most extensive surface
wounds seen in surgery. Though the treatment of burn
wounds has progressed over time, their management still
provides considerable challenges. To date, there is still a
remarkable mortality rate in burn victims in developing
countries.
With improved resuscitation of the burn patients, the
major etiologies of mortality in this population include in-
halation injury, adult respiratory distress syndrome (ARDS)
and sepsis ranging from systemic inflammatory response
syndrome (SIRS) to frank septic shock.19 Wound infection,
especially by nosocomial and opportunistic infections, are
the main cause of sepsis in burned children. As a result,
a growing cause of concern in burn victims is coloniza-
tion of burn wounds by multidrug resistant organisms. 
In a survey based on the data from 176 burn care cen-
ters in North America, Pseudomonas species was found to
be the most important cause of life threatening infections
in patients with thermal injuries.20 Similarly, McManus et
al. in a 25-year review of Pseudomonas bacteremia in burn
patients demonstrated that bacteremia due to P. aerugi-
nosa caused an overall burn mortality of 77% which was
28% higher than predicted.21 Revathi et al. also reported
their experience in 600 infected burn patients.22 They
showed that Pseudomonas spp. and Staphylococcus aure-
ous caused the most common and severe infections fol-
lowed by other Gram-negative organisms. In a study by
Gastmeier on pediatric burn patients with hospital acquired
infections, the most frequently isolated pathogens were
Staphylococcus aureous (20.7%) and Pseudomonas spp.
(14.6%), followed by Enterococcus spp. and Escherichia
coli (both 12.2%).23
In a study by Ganesamoni et al. conducted on burn
patients, Pseudomonas aeroginosa was the most common
organism identified followed by Acinetobacter species.
They also showed that these strains were resistant to the
majority of the commonly used antibiotics.24 According to
their results, amikacin and ceftriaxone had only less than
20% in vivo activity and only around one third of isolates
of P. aeroginosa and a similar percentage of Acinetobac-
ter spp. were sensitive to meropenem. This study empha-
sized the increasing prevalence of Pseudomonas coloniza-
tion in burn wounds compared to the previously reported
series. Furthermore, prevalence of Acinetobacter has also
been reported to have increased in western studies.22, 25-30
However, Acinetobacter infection has not been demon-
strated to affect mortality independently.31
In this study, 15.9% of P. aeroginosa and Acineto-
bacter isolates were found to produce carbapenemase i.e.
VIM (a metallo-beta-lactamase, MBL). Also, 63% of P.
aeroginosa and Acinetobacter isolates harbored SHV and
TEM-typed ESBL while only 14% of isolates harbored
PER, as an ESBL. Approximately 5% of isolates had both
“class A” ESBLs, (i.e. SHV and TEM). 
The present study revealed a high prevalence of β-lac-
tamase producing genes in burn wounds colonized by
Pseudomonas or Acinetobacter species. It seems that ex-
tended spectrum β-lactamase producing genes, including
TEM-type ESBL encoding genes followed by SHV genes,
are responsible for the majority of emerging resistance to
β-lactams in the pediatric burn unit of our hospital. The
roles of PER-type ESBL and VIM (a MBL) are less con-
spicuous.
Sepehriseresht et al. evaluated vim1, vim2, ipm1 and
ipm2 metallo-β-lactamase encoding genes in imipenem-re-
sistant and intermediate P. aeruginosa strains isolated from
burn wounds.32 Among the 483 isolates evaluated in their
study, 272 (56%) were imipenem-resistant with a growth
zone of < 13mm, 63 (13%) isolates had intermediate pat-
tern in their imipenem antibiogram with a growth zone be-
tween 13-15mm, and 148 (31%) isolates were susceptible
to imipenem with a growth zone of > 15 mm. PCR assay
for vim1, vim2, ipm1 and ipm2 genes were done for the
isolates with resistant and intermediate patterns to imipen-
em. Results of DNA sequencing by PCR showed that 54
(16.1%), 7 (2.1%), 22 (6.6%), and 11 (3.3%) of these iso-
lates had vim1, vim2, ipm1 and ipm2 genes, respectively.
The incidences of vim1, vim2, ipm1 and ipm2 genes among
the imipenem-resistant isolates were 15.4%, 1.8%, 6.6%,
and 3.3%, respectively; while intermediate isolates, had
frequencies of 4.8%, 3.1%, 6.3%, and 3.1%, respectively.
However, in another study conducted in our hospital, Saderi
et al. found that 38.28% of 128 clinical isolates of P. aerug-
inosa were resistant to imipenem.33 Shahcheraghi et al. as-
sessed 350 clinical isolates of P. aeruginosa from two gen-
eral hospitals in Tehran, Iran and demonstrated that only
5% of the isolates were imipenem-resistant.34
According to our study, and also in comparison with
the study by Sepehriseresht et al., it seems that prevalence
of VIM-typed MBL genes in the isolates of P. Aeruginosa
has been in a steady state from 2008 to 2012.32 However,
data regarding the time-dependent changes in the preva-
lence of ESBL genes in P. aeruginosa and Acinetobacter
spp. and also of MBL encoding genes in Acinetobacter
spp. are less available. However, Rasmussen and Bush be-
Type of gene Frequency Percent
PER 15 14.0
SHV 28 26.2
TEM 40 37.4
VIM 17 15.9
SHV, TEM 5 4.7
PER, SHV, TEM 1 .9
SHV, TEM, VIM 1 .9
Table I - Distribution of β-lactamase producing genes
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lieved that as carbapenems use goes up, an increase in
MBL-producing organisms would be inevitable.35 Consis-
tently, a study by Lee et al. revealed that after nine years
use of carbapenems in Korea, the imipenem-resistance rate
of P. aeruginosa rapidly raised from 6% in 1996 to 19%
in 2001.36 Shibata et al. demonstrated that 35%, 0.5%, and
64.5% of 180 isolates of P. aeroginosa had vim2, ipm1,
and ipm2- typed MBL genes, respectively.37 Laupland et
al. also found a 92% prevalence of vim2 positive isolates
of P. aeroginosa isolates in the Calgary Health Region in
Canada between May 2002 and April 2004.38 Lee et al.
showed prevalences of 1.7% and 0% of vim2 and imp1
MBLs among 415 clinical isolates of P. aeroginosa in Ko-
rea, respectively.39 These findings reinforce the fact that
geographical conditions, hygienic states and chromosomal
and plasmid differences of the isolated organism lead to
different prevalence of MBLs all over the world. 
Azimi et al. evaluated the prevalence of Carbapene-
mase (KPC) among isolated Pseudomonas aeruginosa and
Acinetobacter spp. at a tertiary burn hospital in Tehran,
Iran.40 They isolated 64 strains from 20 patients with TB-
SA burns of 15-40% and an age range of 0-6 years. The
isolated strains included 28 Gram-positive bacteria, 16 En-
terobacteriacea, 12 Pseudomonas and 7 Acinetobacter bau-
mannii. Among 36 Gram-negative isolates, 10 isolates were
resistant to all tested antibiotics except Colistin and 10 iso-
lates were susceptible to at least one aminoglycoside. More-
over, 15 out of 36 isolates including 6 Pseudomonas aerug-
inosa, 6 Acintobacter baumannii and 3 Klebsiella pneu-
monia strains were found to be imipenem-resistant. Final-
ly, 13 out of 15 imipenem-resistant strains were confirmed
as KPC-producing organisms. In detail, four of six imipen-
em-resistant Pseudomonas strains, all six imipenem-resist-
ant Acinetobacter baumannii strains and all three imipen-
em-resistant Klebsiella pneumoniae strains were produc-
ing KPC. Only six out of 36 isolated strains were ESBL
producers; while four strains were both KPC and ESBL
positive.
Similarly, Shakibaei et al. evaluated the presence of
SHV, TEM and PER type extended-spectrum β-lactamase
genes among clinical strains of Pseudomonas aeroginosa
isolated from burnt patients at Shafa hospital, Kerman,
Iran.41 Amongst 120 isolates of P. aeroginosa collected
from 245 patients in the burn unit, 41 isolates (34%) were
found to be ESBL producers; while none of the isolates
produced MBL. The PCR assay of these ESBL producing
isolates of P. aeroginosa demonstrated prevalences of 6.6%,
4.1% and 2.5% for SHV, PER and TEM type ESBL genes,
respectively. Furthermore, Shojapour et al assessed the
prevalence of TEM-1 type ESBL gene in Pseudomonas
aeroginosa strains isolated from burn wounds in Shahreko-
rd, Iran.42 They found 66 (37.7%) ESBL positive isolates
among all 175 studied Pseudomonas aeruginosa isolates;
and 15.15% of them were positive for TEM-1 gene. Sim-
ilarly, Ranjbar et al also evaluated the characteristics of
Pseudomonas aeruginosa strains isolated from burned pa-
tients hospitalized in our hospital.43 They studied a total of
70 P. aeruginosa isolates obtained from different clinical
origins. They showed that 100% of P. aeruginosa strains
were resistant to cefoxitin, 97% to cefotetan, 93% to ticar-
cillin, 89% to ticarcillin/clav, 76% to gentamicin and
imipenem, 63% to piperacillin, 49% to tetracycline, and
20% to meropenem. However, they did not assess the
prevalence of beta-lactamase producing genes in their
Pseudomonas aeroginosa strains. 
Although the antibiotic resistance of Acinetobacter
spp. has been assessed in isolates recovered from gener-
al hospitals, especially ICUs, in Iran,44, 45 there is limited
information regarding the antibiotic resistance of Acine-
tobacter spp. isolated from burn patients in Iran. It has
been reported that most of the VIM-positive isolates
(76%) of Acinetobacter spp. were multidrug-resistant.
While it has recently been found that increased expres-
sion of chromosomal genes for efflux systems plays a
major role in multidrug resistance, the role of beta-lac-
tamase producing genes in the emerging resistance of
Acinetobacter spp should also be seriously considered, as
shown previously.46, 47
Schlager et al. showed a significantly higher rate of
burn wound infection in patients with >20% TBSA as
compared to the patients with <20% TBSA burn injury.48
Their results were in accordance with those reported by
Weber et al. and Gastmeier et al., who also found a close
association between the burn size and burn wound infec-
tion. The effects of TBSA on the development of burn
wound infections could be explained by the fact that larg-
er burn wounds increase the likelihood of wound con-
tamination.23, 49-50
Our study has several limitations which need to be dis-
cussed. First, we used a relatively small sample size. Sec-
ond, we did not assess the antibiogram pattern of the strains
to decide the in vitro consequences of the presence of ex-
tended-spectrum β-lactamase-producing and carbapenemase-
producing genes. Furthermore, there is a need for assess-
ment of the clinical outcome of the patients affected by these
strains that would reflect an in vivo reflection of the effects
of these genes in morbidity and mortality of burn victims.
Conclusion
Our findings show that more than half of the
Pseudomonas and Acinetobacter strains in our pediatric burn
unit harbor β-lactamase encoding genes which make them
resistant to a wide range of antibiotics. This might inde-
pendently affect the outcome of our patients. Increased mor-
bidity, mortality and also high treatment costs are conse-
quences of considerable burn wound infections which should
be addressed in future studies with larger sample sizes.
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